(R)-1-(4-Fluoro-2-nitrophenyl)pyrrolidin-3-amine hydrochloride, 95.0%, 1g

TERT-BUTYL (7-BROMOHEPTYL)CARBAMATE, 95.0%, 10g

4-Fluoro-3-formyl-5-methylphenylboronic acid pinacol ester, 98%, 1g

Fase de planificación PLPHi S100x/1,25 objetivo IOS de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm

3-BROMOQUINOLINE-6-SULFONYL CHLORIDE, 95.0%, 100mg

1-(difluoromethoxy)-3-nitrobenzene, 98%, 100g

3-(1H-pyrazol-1-yl)propanoic acid hydrochloride, 95.0%, 1g

1-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-yl)-pyrrolidin-3-ol, 95.0%, 100mg

4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(2,2,2-TRIFLUOROETHYL)-1H-PYRAZOLE, 95.0%, 5g

4-BROMO-5-METHYLBENZENE-1,3-DIOL, 95.0%, 5g

ISOPROPYL ((R)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)-D-ALANINATE, 95%, 1mg

1,2-Dimethyl-3-propylimidazolium Iodide, >98.0%(HPLC)(T), 25g

5-CHLORO-1-METHYLINDOLIN-2-ONE, 95%, 1g